Provided by Tiger Fintech (Singapore) Pte. Ltd.

Supernus Pharmaceuticals

32.04
-0.5900-1.81%
Post-market: 32.040.00000.00%16:03 EDT
Volume:290.00K
Turnover:9.33M
Market Cap:1.79B
PE:28.94
High:32.67
Open:32.54
Low:32.02
Close:32.63
Loading ...
Jul 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 24, 2024

Major Issues Report

Form 8-K - Current report
Jul 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
May 23, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
Apr 24, 2024

Major Issues Report

Form 8-K - Current report
Apr 24, 2024

Major Issues Report

Form 8-K - Current report
Apr 08, 2024

Major Issues Report

Form 8-K - Current report
Mar 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities